CHINA MEDICAL SYSTEM HOLDINGS LIMITED (8A8)
General Announcement: NDA of Recombinant Fully Human Bispecific Antibody Against RABV Silevimig Approved in China
General Announcement: NDA of Recombinant Fully Human Bispecific Antibody Against RABV Silevimig Approved in China
There are no comments here yet...